BSX

BSX

USD

Boston Scientific Corporation Common Stock

$98.840-0.140 (-0.141%)

Prix en Temps Réel

Healthcare
Dispositifs médicaux
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$98.980

Haut

$99.310

Bas

$98.250

Volume

4.81M

Fondamentaux de l'Entreprise

Capitalisation Boursière

146.5B

Industrie

Dispositifs médicaux

Pays

United States

Statistiques de Trading

Volume Moyen

8.69M

Bourse

NYQ

Devise

USD

Intervalle sur 52 Semaines

Bas $84.13Actuel $98.840Haut $109.5

Actualités Connexes

Analyst Upgrades

Truist Securities Maintains Buy on Boston Scientific, Raises Price Target to $130

Truist Securities analyst Richard Newitter maintains Boston Scientific with a Buy and raises the price target from $129 to $130.

Voir plus
Truist Securities Maintains Buy on Boston Scientific, Raises Price Target to $130
Analyst Upgrades

Wells Fargo Maintains Overweight on Boston Scientific, Raises Price Target to $125

Wells Fargo analyst Larry Biegelsen maintains Boston Scientific with a Overweight and raises the price target from $124 to $125.

Voir plus
Wells Fargo Maintains Overweight on Boston Scientific, Raises Price Target to $125
Analyst Upgrades

Morgan Stanley Maintains Overweight on Boston Scientific, Raises Price Target to $130

Morgan Stanley analyst Patrick Wood maintains Boston Scientific with a Overweight and raises the price target from $125 to $130.

Voir plus
Morgan Stanley Maintains Overweight on Boston Scientific, Raises Price Target to $130
Analyst Upgrades

BTIG Reiterates Buy on Boston Scientific, Maintains $132 Price Target

BTIG analyst Marie Thibault reiterates Boston Scientific with a Buy and maintains $132 price target.

Voir plus
BTIG Reiterates Buy on Boston Scientific, Maintains $132 Price Target
Analyst Upgrades

Boston Scientific Gains Momentum As Growth Broadens, Goldman Sachs Says

Goldman Sachs analyst David Roman reiterated a Buy rating and $120 price target for Boston Scientific after strong Q3 results and raised guidance.

Voir plus
Boston Scientific Gains Momentum As Growth Broadens, Goldman Sachs Says
PR Newswire

Boston Scientific announces results for third quarter 2025

Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.065 billion during the third quarter of 2025, growing 20.3 percent on a reported...

Analyst Upgrades

Evercore ISI Group Maintains Outperform on Boston Scientific, Lowers Price Target to $110

Evercore ISI Group analyst Vijay Kumar maintains Boston Scientific with a Outperform and lowers the price target from $115 to $110.

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.